Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2012

01.11.2012 | Reproductive Medicine

Fundamental role of folliculo-luteal function in recurrent miscarriage

verfasst von: György S. Siklósi, Ferenc G. Bánhidy, Nándor Ács

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To re-evaluate the role of folliculo-luteal function (FLF) in recurrent miscarriage (RM) on the basis of new hormonal diagnostic criteria.

Methods

A prospective, randomized, single-blinded, placebo-controlled study was carried out at 110 apparently healthy patients with three or more miscarriages not related to any presumable predisposing factors of RM were investigated. In the treatment group FLF was normalized preconceptionally. Women in the control group received placebo. FLF was regarded as physiological when the mean of three progesterone (P) values measured every second day between the 4th and 9th day after ovulation or before menstruation was 21.0 ± 2.0 ng/ml.

Results

A significant difference (p < 0.001) was found between the physiological and placebo groups in the occurrence of live births: 93 versus 56 %, pregnancy losses: 7 versus 44 %; premature delivery per births: 10 versus 57 %. Luteal mean P and estradiol values were significantly (p < 0.001) different in cases of spontaneous abortions and premature and mature deliveries, respectively (P: 14.6 ± 2.2, 20.2 ± 2.7, 27.6 ± 3.9 ng/ml). A strong and significant correlation (p < 0.001) was found between luteal mean P values and the duration of pregnancy (r = 0.85), as well as between the P means measured in the luteal phase and different parameters of the newborns: weight (r = 0.89), weight percentile (0.86) and length (0.73). Retrospective analysis of our data suggests that a luteal P mean value of 29.3 ± 2.9 ng/ml characterising patients with singular, mature, eutroph newborns seems to be the most favorable P value for successful reproduction in RM.

Conclusion

Determining the oocyte quality and placentation, FLF quantitatively determines the outcome of pregnancy: its duration and different characteristics of the newborns in RM.
Literatur
1.
Zurück zum Zitat Li TC, Makris M, Tomsu M, Tuckerman E, Laird S (2002) Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 8:463–481PubMedCrossRef Li TC, Makris M, Tomsu M, Tuckerman E, Laird S (2002) Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 8:463–481PubMedCrossRef
2.
Zurück zum Zitat Christiansen OB, Andersen NAM, Bosch E, Daya S, Delvers PJ, Hviid TV et al (2005) Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 83:821–839PubMedCrossRef Christiansen OB, Andersen NAM, Bosch E, Daya S, Delvers PJ, Hviid TV et al (2005) Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 83:821–839PubMedCrossRef
3.
4.
Zurück zum Zitat Tang A-W, Quenby S (2010) Recent thoughts on management and prevention of recurrent early pregnancy loss. Curr Opin Obstet Gynecol 22:446–451PubMedCrossRef Tang A-W, Quenby S (2010) Recent thoughts on management and prevention of recurrent early pregnancy loss. Curr Opin Obstet Gynecol 22:446–451PubMedCrossRef
5.
Zurück zum Zitat Berry CW, Brambati B, Eskes TK, Exalto N, Fox H, Geraedts JP, Gerhard I, Gonzales Gomes F, Grudzinskas JG, Hustin J et al (1995) The Euro–Team Early Pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod 10:1516–1520PubMed Berry CW, Brambati B, Eskes TK, Exalto N, Fox H, Geraedts JP, Gerhard I, Gonzales Gomes F, Grudzinskas JG, Hustin J et al (1995) The Euro–Team Early Pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod 10:1516–1520PubMed
6.
Zurück zum Zitat Jaslow CR, Carney JL, Kuttech WH (2010) Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 93:1234–1243PubMedCrossRef Jaslow CR, Carney JL, Kuttech WH (2010) Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 93:1234–1243PubMedCrossRef
7.
Zurück zum Zitat Jones GS (1991) Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol 3:641–648PubMed Jones GS (1991) Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol 3:641–648PubMed
8.
Zurück zum Zitat Mitwally MFM, Casper RF, Diamond MP (2005) The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment. Reprod Biol Endocrinol 3:54–99PubMedCrossRef Mitwally MFM, Casper RF, Diamond MP (2005) The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment. Reprod Biol Endocrinol 3:54–99PubMedCrossRef
9.
Zurück zum Zitat Davis OK, Berkeley AS, Naus GJ, Cholst IN, Freedman KS (1989) The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertil Steril 51:582–586PubMed Davis OK, Berkeley AS, Naus GJ, Cholst IN, Freedman KS (1989) The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertil Steril 51:582–586PubMed
10.
Zurück zum Zitat Siklósi G, Siklós P, Hintalan A, Olajos F, Marcsek Z (1984) Episodic secretion of hormones and the diagnostic value of single blood estimates. II. Progesterone, oestradiol and oestrone. Acta Med Hung 41:203–211PubMed Siklósi G, Siklós P, Hintalan A, Olajos F, Marcsek Z (1984) Episodic secretion of hormones and the diagnostic value of single blood estimates. II. Progesterone, oestradiol and oestrone. Acta Med Hung 41:203–211PubMed
11.
Zurück zum Zitat Filicori M, Butler JP, Crowley WF Jr (1984) Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 73:1638–1647PubMedCrossRef Filicori M, Butler JP, Crowley WF Jr (1984) Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 73:1638–1647PubMedCrossRef
12.
Zurück zum Zitat Siklósi G (1991) Luteal insufficiency and habitual abortion. In: Hafez ESE (ed) Assisted human reproductive technology. Part two: advances in reproductive endocrinology. Hemisphere Publ. Co, New York, pp 49–60 Siklósi G (1991) Luteal insufficiency and habitual abortion. In: Hafez ESE (ed) Assisted human reproductive technology. Part two: advances in reproductive endocrinology. Hemisphere Publ. Co, New York, pp 49–60
13.
Zurück zum Zitat Siklósi G (1992) Luteal insufficiency as the primary cause of habitual abortion—its successful treatment. Acta Biol Med 63:101–111 Siklósi G (1992) Luteal insufficiency as the primary cause of habitual abortion—its successful treatment. Acta Biol Med 63:101–111
14.
Zurück zum Zitat American Society for Reproductive Medicine (2006) Practice Committee Use of clomiphene citrate in women. Fertil Steril 86(Suppl 4):187–193 American Society for Reproductive Medicine (2006) Practice Committee Use of clomiphene citrate in women. Fertil Steril 86(Suppl 4):187–193
15.
Zurück zum Zitat Dickey RP, Holtkamp DE (1995) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 62:483–506 Dickey RP, Holtkamp DE (1995) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 62:483–506
16.
Zurück zum Zitat Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R (2002) Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril 78:1088–1095PubMedCrossRef Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R (2002) Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril 78:1088–1095PubMedCrossRef
17.
Zurück zum Zitat Serle E, Aplin JD, Li TC, Warren MA, Graham RA, Seif MW, Cooke ID (1994) Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril 62:989–996PubMed Serle E, Aplin JD, Li TC, Warren MA, Graham RA, Seif MW, Cooke ID (1994) Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril 62:989–996PubMed
18.
Zurück zum Zitat Kupesic S, Kurjak A (1997) The assessment of normal and abnormal luteal function by transvaginal color Doppler sonography. Eur J Obstet Gynecol Reprod Biol 72:83–87PubMedCrossRef Kupesic S, Kurjak A (1997) The assessment of normal and abnormal luteal function by transvaginal color Doppler sonography. Eur J Obstet Gynecol Reprod Biol 72:83–87PubMedCrossRef
19.
Zurück zum Zitat Kato K, Mostafa MH, Mann K, Schindler AE, Hoermann R (2002) Human chorionic gonadotrophin exhibits normal biological activity in patients with recurrent pregnancy loss. Gynecol Endocrinol 16:179–216PubMed Kato K, Mostafa MH, Mann K, Schindler AE, Hoermann R (2002) Human chorionic gonadotrophin exhibits normal biological activity in patients with recurrent pregnancy loss. Gynecol Endocrinol 16:179–216PubMed
20.
Zurück zum Zitat Muttukrishna S, Jauniaux E, Greenwold N, McGarrigle H, Jivraj S, Carter S, Elgaddal S, Groome N, Regan L (2002) Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 17:3072–3078PubMedCrossRef Muttukrishna S, Jauniaux E, Greenwold N, McGarrigle H, Jivraj S, Carter S, Elgaddal S, Groome N, Regan L (2002) Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 17:3072–3078PubMedCrossRef
21.
Zurück zum Zitat Bromer G, Aldad TS, Taylor HS (2009) Defining the proliferative phase endometrial defect. Fertil Steril 91:698–704PubMedCrossRef Bromer G, Aldad TS, Taylor HS (2009) Defining the proliferative phase endometrial defect. Fertil Steril 91:698–704PubMedCrossRef
22.
Zurück zum Zitat Li TC, Tuckerman E, Laird S (2002) Endometrial factors in recurrent miscarriage. Hum Reprod Update 8:43–45 Li TC, Tuckerman E, Laird S (2002) Endometrial factors in recurrent miscarriage. Hum Reprod Update 8:43–45
23.
Zurück zum Zitat Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ (2010) Molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod 16:886–895PubMedCrossRef Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ (2010) Molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod 16:886–895PubMedCrossRef
24.
Zurück zum Zitat Raghupathy R, Al-Mutawa E, Al-Azemi M, Makhseed M, Azizieh F, Szekeres-Bartho J (2009) Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol 80:91–99PubMedCrossRef Raghupathy R, Al-Mutawa E, Al-Azemi M, Makhseed M, Azizieh F, Szekeres-Bartho J (2009) Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol 80:91–99PubMedCrossRef
Metadaten
Titel
Fundamental role of folliculo-luteal function in recurrent miscarriage
verfasst von
György S. Siklósi
Ferenc G. Bánhidy
Nándor Ács
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2433-0

Weitere Artikel der Ausgabe 5/2012

Archives of Gynecology and Obstetrics 5/2012 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.